NOX1 and colonic neoplasm: Stable genetic inhibition of NOX1 with shRNA significantly diminishes the proliferation of HT-29 cells that possess functional NOX1, but not of the HCT116 human colon cancer line that lacks an active NADPH oxidase [4].